Suppliers / Wuxi Jida Pharmaceutical

Wuxi Jida Pharmaceutical

China Updated 9 July 2026

Wuxi Jida Pharmaceutical is an API manufacturer based in China. It holds 3 active US drug master files and 2 valid CEPs across a filed portfolio of 3 molecules.

3
active US DMFs
2
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Jiangyin, China Not on file

What they file, and where

Molecule Regulators Docs
Citalopram EDQM, US FDA 2
Risperidone EDQM, US FDA 2
Escitalopram US FDA 1

Also appears on these molecule pages

Questions about Wuxi Jida Pharmaceutical

Does Wuxi Jida Pharmaceutical hold a US DMF or a CEP?
Wuxi Jida Pharmaceutical holds 3 active US drug master files and 2 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Wuxi Jida Pharmaceutical manufacture?
1 registered site is on record, in China (Jiangyin). Every site is listed on this page with the register it came from.
What does Wuxi Jida Pharmaceutical make?
3 molecules are on record against Wuxi Jida Pharmaceutical, including Citalopram, Risperidone and Escitalopram. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Wuxi Jida Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability